Authors:
Tang, Y
Osawa, H
Onuma, H
Nishimiya, T
Ochi, M
Sugita, A
Makino, H
Citation: Y. Tang et al., Phosphodiesterase 3B gene expression is enhanced in the liver but reduced in the adipose tissue of obese insulin resistant db/db mouse, DIABET RE C, 54(3), 2001, pp. 145-155
Authors:
Darko, DA
Dornhorst, A
Kennedy, G
Mandeno, RC
Seed, M
Citation: Da. Darko et al., Glycaemic control and plasma lipoproteins in menopausal women with Type 2 diabetes treated with oral and transdermal combined hormone replacement therapy, DIABET RE C, 54(3), 2001, pp. 157-164
Citation: Tk. Tso et al., Risk factors for coronary heart disease in type 1 diabetic children: the influence of apoE phenotype and glycemic regulation, DIABET RE C, 54(3), 2001, pp. 165-171
Authors:
Suzuki, K
Kato, K
Hanyu, O
Nakagawa, O
Aizawa, Y
Citation: K. Suzuki et al., Left ventricular mass index increases in proportion to the progression of diabetic nephropathy in Type 2 diabetic patients, DIABET RE C, 54(3), 2001, pp. 173-180
Authors:
Nakamura, T
Funahashi, T
Yamashita, S
Nishida, M
Nishida, Y
Takahashi, M
Hotta, K
Kuriyama, H
Kihara, S
Ohuchi, N
Nishimura, T
Kishino, B
Ishikawa, K
Kawamoto, T
Tokunaga, K
Nakagawa, C
Mineo, I
Watanabe, F
Tarui, S
Matsuzawa, Y
Citation: T. Nakamura et al., Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation - double-blind placebo-controlled trial, DIABET RE C, 54(3), 2001, pp. 181-190
Citation: S. Baba, Nifedipine and enalapril equally reduce the progression of nephropathy in hypertensive type 2 diabetics, DIABET RE C, 54(3), 2001, pp. 191-201
Authors:
Erem, C
Yildiz, R
Kavgaci, H
Karahan, C
Deger, O
Can, G
Telatar, M
Citation: C. Erem et al., Prevalence of diabetes, obesity and hypertension in a Turkish population (Trabzon city), DIABET RE C, 54(3), 2001, pp. 203-208
Citation: Y. Tokuyama et al., A patient with subcutaneous-insulin resistance treated by insulin lispro plus heparin, DIABET RE C, 54(3), 2001, pp. 209-212
Authors:
Dzien, A
Dzien-Bischinger, C
Hoppichler, F
Lechleitner, M
Citation: A. Dzien et al., Fasting glucose concentrations and cardiovasular disease; are the new diagnostic criteria not strict enough?, DIABET RE C, 54(3), 2001, pp. 213-214
Authors:
Iwase, M
Gotoh, D
Urata, M
Kang, D
Hamasaki, N
Yoshinari, M
Fujishima, M
Citation: M. Iwase et al., Clinical features of diabetic patients with 0.01-0.1% heteroplasmy A3243G mutation in leukocyte mitochondrial DNA, DIABET RE C, 54(3), 2001, pp. 215-217
Authors:
Kumaramanickavel, A
Sripriya, S
Vellanki, RN
Upadyay, NK
Badrinath, SS
Arokiasamy, T
Sukumar, B
Vidha, A
Joseph, B
Sharma, T
Gopal, L
Citation: A. Kumaramanickavel et al., Tumor necrosis factor allelic polymorphism with diabetic retinopathy in India, DIABET RE C, 54(2), 2001, pp. 89-94
Authors:
Araz, M
Yilmaz, N
Gungor, K
Okan, V
Kepekci, Y
Aynacioglu, AS
Citation: M. Araz et al., Angiotensin-converting enzyme gene polymorphism and microvascular complications in Turkish type 2 diabetic patients, DIABET RE C, 54(2), 2001, pp. 95-104
Authors:
Tamas, G
Marre, M
Astorga, R
Dedov, I
Jacobsen, J
Lindholm, A
Citation: G. Tamas et al., Glycaemic control in type I diabetic patients using optimised insulin aspart or human insulin in a randomised multinational study, DIABET RE C, 54(2), 2001, pp. 105-114
Citation: D. Olaleye et al., Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic, DIABET RE C, 54(2), 2001, pp. 115-128
Authors:
Migdalis, IN
Kalogeropoulou, B
Iliopoulou, V
Triantafilou, P
Charalabides, J
Mortzos, G
Cordopatis, C
Citation: In. Migdalis et al., Plasma levels of endothelin, lipid peroxides and prostacyclin in diabetic patients with macroangiopathy, DIABET RE C, 54(2), 2001, pp. 129-136
Authors:
Taniguchi, T
Okamoto, M
Ueno, H
Tanaka, J
Okamoto, M
Hamasaki, A
Yamada, Y
Seino, Y
Citation: T. Taniguchi et al., Use of the insulin sensitivity index obtained from oral glucose tolerance test in Japanese subjects, DIABET RE C, 54(2), 2001, pp. 143-144
Authors:
Hirose, T
Miyashita, Y
Takagi, M
Sumitani, S
Kouhara, H
Kasayama, S
Citation: T. Hirose et al., Characteristics of type 2 diabetic patients responding to voglibose administration as an adjunct to sulfonylurea, DIABET RE C, 54(1), 2001, pp. 9-15
Citation: Bh. Chen et al., GAD65 antibody prevalence and association with thyroid antibodies, HLA-DR in Chinese children with type I diabetes mellitus, DIABET RE C, 54(1), 2001, pp. 27-32
Authors:
Vanizor, B
Orem, A
Karahan, SC
Kiran, E
Erem, C
Aliyazicioglu, R
Uydu, HA
Citation: B. Vanizor et al., Decreased nitric oxide end-products and its relationship with high densitylipoprotein and oxidative stress in people with type 2 diabetes without complications, DIABET RE C, 54(1), 2001, pp. 33-39